跳至主要内容
临床试验/NCT06838754
NCT06838754已完成不适用

Effects of Whole Body Vibration on Gait Parameters and Postural Control in Children With Down Syndrome

Riphah International University1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2024年10月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
1
主要终点
Step length

研究概览

简要总结

A congenital condition known as Down syndrome is typified by an excess of genetic material from chromosome 21, making 47 chromosomes in total. Development of the body and brain may be impacted. About 1 in 700-1100 live births have the condition, and 1 in 700-1100 live births inherit it. Heart disease, hypotonia, ligament laxity, cerebral disabilities, thyroid abnormalities, and metabolic diseases are among the physical, cognitive, and metabolic changes that define it. Reduced performance, increased energy consumption, and altered gait patterns are frequently the results of motor disorders. This study intends to ascertain the effects of whole body vibrations (WBV), an activity that has been recommended for individuals with Down syndrome, on gait parameters and postural control in children with this condition.

详细描述

Whole Body Vibration (WBV) and routine physical therapy (RPT) are given to Group A, whereas routine physical therapy is given to Group B as a control. Two sessions of 20 minutes each are given to both groups twice a week. Postural control and gait metrics are the outcomes that will be examined. The present investigation will be conducted over a two-month period and will be a randomized control experiment. Alkhidmat Hospital in Sargodha and Al-Ghafoor Hospital in Bhera will provide the data. 16 participants will participate in the trial; they will be randomly assigned to two equal groups. Children with DS, ages 5 to 12, of both sexes, will be eligible to participate in the study. The condition of improved comprehension of children older than five years was taken into consideration when determining the inclusion criteria.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Participants will receive separate treatment protocols and possible effects will be put to mask the both group about the treatment.

入排标准

年龄范围
5 Years 至 12 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Ages 5-12
  • •Both sexes are chosen
  • •Children with Down syndrome older than 5 who are more knowledgeable about the exercise to be done are given preference.

排除标准

  • •Children with cardiac conditions and other conditions
  • •Atlantoaxial instability and prosthesis implantation are excluded.
  • •DS kids who don't have their parents or legal guardians sign the consent form.

研究组 & 干预措施

Whole body vibration therapy

Experimental

Experimental group will receive whole body vibrations while sitting. Walking in all directions,

干预措施: Whole body vibration therapy (Other)

Routine physical therapy

Other

Group B will be the only one performing routine physical therapy (RPT). Stretching exercises will be part of these regular workouts. Walking in all directions,

干预措施: Routine physical therapy (Other)

结局指标

主要结局

Step length

时间窗: 2 months.

Step length will be measured from consecutive heel contacts in cm.

Posture and postural ability test (PPAS)

时间窗: 2 months.

The PPAS assesses 4 positions. Standing, sitting, supine and prone Each position is assessed according to the postural ability, quality of posture and within postural ability seven levels are designated, ranging from Level 1 = 'Unplaceable in an aligned posture' to 7 = Able to move into and out of position.

Stride length

时间窗: 2 months.

Stride length is the distance between the previous heel strike of the right foot and the new heel strike of the right foot and measured in cm.

Step width

时间窗: 2 months.

Step width will be measured from the mediolateral space between the two feet in cm.

Foot angle

时间窗: 2 months.

Foot angle will be measured by the angle between the line of progression and the foot axis in degree.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Effect of Whole Body Vibration on Down Syndrome | 临床试验